Search
for
Sort by
Research 241–270 of 1000+
- Anthracycline analogs The past, present, and future
- Cellular senescence in skin‐related research: Targeted signaling pathways and naturally occurring therapeutic agents
- Hollow polydopamine nanoparticles loading with peptide RL-QN15: a new pro-regenerative therapeutic agent for skin wounds
- Recent advances on skin‐resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti‐aging and cancer therapies
- Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
- 3D Printed Hollow Microneedles for Treating Skin Wrinkles Using Different Anti-Wrinkle Agents: A Possible Futuristic Approach
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Chemotherapy-Induced Alopecia in Ovarian Cancer: Incidence, Mechanisms, and Impact Across Treatment Regimens
- The effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- Therapies and nanotherapies for cervical cancer (Review)
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- The Administration of Ocoxin Increases the Quality of Life of Patients with Advanced Epithelial or Metastatic Ovarian Cancer Undergoing Neoadjuvant Chemotherapy
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Topical delivery of nanoemulsions for skin cancer treatment
- Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
- Pancreatic cancer
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- Androgens in cervical cancer: Their role in epidemiology and biology
- Induction of ferroptosis by natural products in non-small cell lung cancer: a comprehensive systematic review
- Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients
- Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study
- Exploring extracellular vesicles as novel therapeutic agents for intervertebral disc degeneration: delivery, applications, and mechanisms
- Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes